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Abstract
Objective : To review the outcome of percutaneous mitral 
balloon commissurotomy (PMBC) both to maternal and 
neonatal survivalbility
Methods : The search was conducted on Pubmed®, 
Cochrane Library®, and Ovid® using MeSH. Critical appraisal 
determining the validity, importance, and applicability (VIA) 
was conducted by two independent authors. Preganant 
woment with MS with functional class grading based on 
NYHA
Results : Several studies showed that performing the PMBC 
had good outcome for pregnant women functional class 
based on NYHA. Most of them decreased from NYHA III/IV 
to I/II. For delivery outcome, all studies concluded that more 
than 80% pregnant women with mitral stenosis undergoing 
PMBC delivered at term, and no congenital anomalies found.
Conclusions :  A decrease in NYHA functional class 
was observed after PMBC Percutaneous mitral balloon 
commissurotomy for pregnant women with severe MS is 
safe during pregnancy.
Keywords : mitral stenosis, outcome, percutaneous mitral 
balloon commissurotomy,  pregnancy.
Abstrak
Tujuan : Mengulas luaran komisurotomi balon mitral 
perkutan (KBMP) baik pada maternal maupun neonatus.
Metode : PPencarian dilakukan melalui Pubmed®, Cochrane 
Library®, dan Ovid® menggunakan MeSH. Telaah kristis 
dilakukan oleh 2 penulis independen berdasarkan validitas, 
kepentingan, dan aplikabilitas.
Hasil : Beberapa studi memperlihatkan KBMP memiliki 
luaran yang baik di kalangan perempuan hamil berdasarkan 
kelas fungsional NYHA. Kebanyakan mereka mengalami 
penurunan NYHA dari III/IV menjadi I/II. Untuk  luaran 
persalinan, seluruh studi menyimpulkan lebih dari 80% 
perempuan dengan mitral stenosis yang menjalani 
pembedahan KBMP melahirkan pada usia term dan tidak 
ditemukan kelainan.
Kesimpulan : KBMP aman dilakukan pada perempuan hamil 
dengan mitral stenosis berat.
Kata kunci : kehamilan, komisurotomibalon mitral perkutan, 
luaran, stenosis mitral.
INTRODUCTION
Normal pregnancy is associated with adaptational 
circulatory state including 40-50% increase in 
cardiac output and decrease in systemic vascular 
resistance.1 The most common valvular heart 
lesion in child-bearing age women is Mitral 
Stenosis (MS).2 It is associated with significant 
maternal and fetal morbidity and mortality.3MS 
in pregancy will cuase an increase in the 
transmitral gradient with raised pressure in the 
pulmonary circulation. Thus, worsening signs of 
dysponea, increase the risk of pulmo edema and 
afib atrial fibrillation leading to thromboembolic 
event. Additionaly, there is also significant risk for 
fetal complications such as premature birth and 
intrauterine growth restriction.4
The management of severe MS can be divided 
into conservative, medical and surgical. All 
women with MS should reduce their activity and 
obtain β-blockers, diuretics, and anticoagulants. 
This regiment can reduce the New York Heart 
Association functional class III/IV to I/II.
Meanwhile, surgical management is indecated 
for patients with failure of aggressive medical 
therapy.4Surgical commissurotomy as a choice 
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is relatively safe with maternal mortality rate of 
≤2%, fetal mortality rate of 1.2% to 8% for closed 
commissurotomy.
Meanwhile, open valvotomy and extracorporal 
cardiopulmonary bypass has fetal mortality 
rate of 15-33%.2Percutaneous mitral balloon 
commissurotomy (PMBC) Has become an 
effective alternative to surgical commissurotomy. 
However, the result of this intervention is still 
limited. Therefore, this study aims to review the 
outcome of PMBC both to maternal and neonatal 
survivalbility.
CASE
A 35-year-old woman, G4P3 with 39 weeks 
of gestational age came to hospital in labour. 
When 4 months of pregnancy, she complained 
continuously shortness of breath, dyspnoea on 
exertion (DOE), orthopnoea (OP), paroxysmal 
nocturnal dyspnoea (PND). There was also cough 
every day without fever. On physical examination, 
there was diastolic murmur on mitral valve and 
rales on both lungs. Complete blood count 
showed within normal limit. Electrocardiography 
revealed atrial fibrillation normal rapid response. 
Echocardiography showed left atrial dilatation, 
normal right atrium and ventricle, MS severe 
(mean PG 8, planimetry MVA 0.61, Wilkins score 
10, MR mild, TR moderate, AR mild-moderate, 
good systolic LV function (EF 73%), hard to 
determine the diastolic LV function, good systolic 
RV function (TAPSE 20). She was diagnosed with 
mitral valve stenosis and undergoing PMBC. The 
procedure was performed on 19-20 weeks of 
gestational age by inserting the Inoue Balloon 
24-26 mm through mitral valve to LV and 
running the PMBC 2 times. After procedure, the 
pressure gradient was around 7-8 mmHg. The 
clinical question is how does PMBC affect the 
survivalbility of pregnant woment with MS?
METHODS
To answer the clinical question, the search was 
conducted on Pubmed®, Cochrane Library®, 
and Ovid®. In PubMed, the search included 
keywords using the MeSH, namely "Mitral Valve 
Stenosis" AND "Pregnancy" AND percutaneous 
mitral commissurotomy. Meanwhile, in Cochrane, 
the MeSH descriptor consisted of [Mitral Valve 
Stenosis] AND [Pregnancy] AND percutaneous 
mitral commissurotomy. The author used 
keywords of Mitral stenosis and Pregnancy and 
percutaneous mitral commissurotomy in Ovid. 
Of the searching strategy above performed 
in June 15th, 2018, there were 17, 0, and 26 
studies in Pubmed®, Cochrane Library®, and 
Ovid® database; respectively. The articles were 
screened using the criteria consisting of abstracts 
answering the clinical question, written in English 
language, full-text paper availability, and omitting 
all duplication papers. After screening, there 
were 5 articles in appropriate to the inclusion 
criteria. Critical appraisal determining the validity, 
importance, and applicability (VIA) was conducted 
by 2 independent authors. The critical appraisal 
steps used in this article (figure 1)5,6
 
17 articles (PubMed) 
10 articles  
5 articles were 
excluded by screening 
the abstract and 
language (1 article was 
written in France and 4 
other articles were 
only available as 
conference abstract)
5 articles  
12 articles  
2 articles had the same 
title 
0 article 
(Cochrane database) 
26 articles (Ovid 
database) 
4 articles  
1 article was excluded 
due to lack of validity 
Figure 1. Flowchart of searching strategy
RESULTS
Of 5 studies appraised, all studies in appropriate 
with VIA criteria based on critical appraisal of 
prognostic study by Centre for Evidence-Based 
Medicine, University of Oxford, 2010. One study 
was considered less valid due to unclear baseline 
characteristics of samples. Besides, the samples 
underwent the PMBC was unclear. Other studies 
used the study samples as severe mitral stenosis 
not responding to standard medical therapy. Due 
to limited cases of severe MS in pregnancy, all 
studies did not run blind fashion for measuring 
the outcome and precision of the prognostic. 
Each study described the results by number of 
patients. Table 1 showed the result of appraisal 
prognostic studies.
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Table 1. Result of VIA on each Prognostic Study
DISCUSSION
The limitation of this study was limited latest 
studies performed in the last 5 years. It might be 
due to limited MS cases in developed countries. 
The best recommendation study for prognostic 
was cohort; however, we could not find any 
literature related with this topic.
Mitral stenosis is the most common cause of 
acquired heart disease during pregnancy. Most 
of MS cases are caused by rheumatic heart 
disease.7 It is poorly tolerated in pregnancy 
due to the huge change of hemodynamic. The 
presence of MS in pregnancy with high cardiac 
output will cause an increase in left atrial and 
pulmonary pressure resulting in pulmonary 
oedema. The normal mitral orifice is 4 to 6 cm 
area by 2D echocardiography short axis. Patient 
usually complains after the valve area less than 
2-2.5 cm with severe MS occurs in valve area less 
than 1 cm. Around 60% of moderate to severe 
MR cases will experience episode of pulmonary 
oedema in 30 weeks of gestational age. This risk 
will continue during and immediate postpartum 
period. The physiological of hypercoagulability 
in pregnancy in relation to increase in left atrial 
pressure will raise the risk of thrombus formation, 
atrial fibrillation (AF), and stroke.8
Surgical commissurotomy as management 
of MS during pregnancy was well-known since 
1952.9Closed or open mitral commissurotomy 
has shown to be an effective procedure 
duringpregnancy but results in high fetal loss thus, 
percutaneous mitral balloon commissurotomy was 
an alternative effective treatment for symptomatic 
MS.10 Several studies showed that performing the 
PMBC had good outcome to pregnant women 
functional class based on NYHA. Most of them 
decreased from NYHA III/IV to I/II.2,3,6  It means 
that there would be a reduction from 6.8% 
mortality rate in NYHA III/IV to 0.4% in NYHA I/
II.11ESC guideline for management of pregnant 
women with MS revealed that percutaneous 
mitral commissurotomy is preferably performed 
after 20 weeks’ gestation. It should only be 
considered in women with NYHA class III/IV and/
or estimated systolic pulmonary artery pressure 
(PAP) >50mmHg at echocardiography after 
optimal medical treatment.12
For delivery outcome, all studies concluded 
that more than 80% pregnant women with mitral 
stenosis undergoing PMBC delivered at term3,5,6 
and2 stated no fetal anomalies found.2 It was 
corresponding to other studies where showed 
Table 1. Result of VIA on each Prognostic Study 
Study Validity Importance Applicability 
Representative 
sample  
Sufficient 
 follow-up 
Outcome 
in a blind 
fashion 
Adjustment for 
important 
prognostic 
factors 
Results 
Precision of 
the 
prognostic 
Similarity 
of patients 
Clinically 
important 
impact 
Sananes, et 
al.5 
Yes (severe mitral 
valve stenosis 
refractory to 
optrimal medical 
therapy) 
Not clear No N/A Delivery outcome
9 patients delivered at term wga 
1 patient delivered preterm due to PROM 
1 patient was still pregnant 
N/A Yes Yes 
Kalra, et al.3 Yes (NYHA class IV 
and not 
responding to 
standard medical 
therapy of CHF) 
Yes (monthly clinical 
and chocardiographic 
assessment and follow 
up 3 monthly intervals 
after that) 
No N/A NYHA outcome 
All patients are in NYHA class I and no 
evidence of restenosis 
Delivery outcome 
24 patients delivered at term 
2 had abortion 
2 patients are still pregnant 
N/A Yes Yes 
Farhat, et 
al.1 
 
No Yes (24 hours before 
and after balloon mitral 
commissurotomy,  
and four to six-month 
interval) 
No N/A NYHA outcome 
40 patients (91%) remain in NYHA class I 
3 patients in NYHA class II 
1 patient in NUHA class IV  
Delivery outcome 
44 patients delivered at term wga (42 
spontaneous and 2 cesarean section 
N/A Yes Yes 
Abouzied, 
et al.2 
Yes (NYHA class III 
and IV; not 
controlled with 
conventional 
medical treatment) 
Yes (every three months 
until delivery of infant) 
No N/A NYHA outcome 
All improved to NYHA class I or II 
Delivery outcome 
14 patients delivered 37 (2) wga 
2 patients delivered (29 and 32 wga) 
11 women had vaginal delivery 
5 women with caesarean section 
N/A Yes Yes 
Dabrowski, 
et al.6 
Yes (symptoms of 
heart failure during 
pregnancy NYHA 
class III) 
Yes (12-21 years) No N/A
 
 
No fetal congenital anomalies
NYHA outcome 
13 NYHA class I 
2 NYHA class II 
Delivery outcome 
12 patients delivered on time (10 spontaneous 
and 2 cesarean sections) 
2 patients delivered prematurely (33rd and 
29thwga) 
Mean AS 8.2 (2.9) 
N/A Yes Yes 
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lower incidence of preterm labor in women 
after percutaneous mitral commissurotomy 
(PMCT) before pregnancy compared with non-
operated MS however13, there were no significant 
differences in mode of delivery, mean birth weight 
or neonatal complications. The radiation is risk 
is balanced with the improvement of symptoms 
after procedure. The fluoroscopy operates in 
the range of 5 rads/minute and less than 20% of 
doses penetrate to the skin. A study measured 
that actual dose received by fetus will not more 
than 0.5 rads therefore, it is no increased risk for 
congenital malformation.14
Ideally, the procedure should be conducted 
before becoming pregnant. If MS is diagnosed in 
early pregnancy, the procedure should be delayed 
up to 12-14 weeks to minimize radiation exposure 
during organogenesis. The best interval time to 
perform is around 26 and 30 weeks to prevent 
complications such as preterm birth.15 Abdominal 
shielding is recommended during procedure. On 
mode of delivery, several studies above showed 
more vaginal delivery than caesarean section. 
Vaginal delivery can be offered to patients with 
mild MS or patients with moderate to severe MS in 
NYHA class I/II without pulmonary hypertension. 
Meanwhile, ESC guideline suggested caesarean 
section for patients with moderate to severe 
MS in NYHA class III/IV or having pulmonary 
hypertension in spite of medical therapy and 
PMCT failed to perform.12
CONCLUSION
Percutaneous mitral balloon commissurotomy for 
pregnant women with severe MS is safe during 
pregnancy; it decreases the NYHA for mother 
and imposes lower risk for preterm birth and 
congenital anomaly.
CONFLICT OF INTEREST
None declared
REFERENCES
